These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29949043)
1. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1. Bogachev VY; Boldin BV; Turkin PY Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043 [TBL] [Abstract][Full Text] [Related]
2. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease. Mezalek ZT; Feodor T; Chernukha L; Chen Z; Rueda A; Sánchez IE; Ochoa AJG; Chirol J; Blanc-Guillemaud V; Lohier-Durel C; Ulloa JH Adv Ther; 2023 Nov; 40(11):5016-5036. PubMed ID: 37728696 [TBL] [Abstract][Full Text] [Related]
3. [Adjuvant phlebotrophic therapy and its effect on anti-inflammatory response after sclerotherapy]. Bogachev VY; Boldin BV; Lobanov VN; Arkadan NR; Ermak MY Angiol Sosud Khir; 2016; 22(4):90-95. PubMed ID: 27935886 [TBL] [Abstract][Full Text] [Related]
4. [Detralex-phlebosclerosing treatment. Results of the national multicenter follow up programme VEIN ACT PROLONGED-C1]. Bogachev VI; Boldin BV; Turkin PI Angiol Sosud Khir; 2018; 24(1):102-106. PubMed ID: 29688201 [TBL] [Abstract][Full Text] [Related]
5. Benefits of micronized purified flavonoid fraction as adjuvant therapy on inflammatory response after sclerotherapy. Bogachev VY; Boldin BV; Lobanov VN Int Angiol; 2018 Feb; 37(1):71-78. PubMed ID: 28945060 [TBL] [Abstract][Full Text] [Related]
6. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids. Jantet G Angiology; 2002; 53(3):245-56. PubMed ID: 12025911 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of MPFF 1000 mg oral suspension on CVD C0s-C1-related symptoms and quality of life. Maggioli A; Carpentier P Int Angiol; 2019 Apr; 38(2):83-89. PubMed ID: 31056892 [TBL] [Abstract][Full Text] [Related]
8. Orthostatic-loading-induced transient venous refluxes (day orthostatic loading test), and remedial effect of micronized purified flavonoid fraction in patients with telangiectasia and reticular vein. Tsukanov YT; Nikolaichuk AI Int Angiol; 2017 Apr; 36(2):189-196. PubMed ID: 27314532 [TBL] [Abstract][Full Text] [Related]
9. [Transitory (evening) venous reflux in patients with intracutaneous varicosity and medicamentous correction thereof]. Tsukanov YT; Nikolaichuk AI Angiol Sosud Khir; 2016; 22(2):110-6. PubMed ID: 27336342 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of once-daily micronized purified flavonoid fraction 1000 mg tablet in patients with symptomatic chronic venous disease. Kirienko A; Radak D; Maggioli A Curr Med Res Opin; 2019 Mar; 35(3):553-557. PubMed ID: 29992831 [TBL] [Abstract][Full Text] [Related]
11. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids. Jantet G Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Kakkos SK; Nicolaides AN Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of micronized purified flavonoid fraction in treatment of chronic venous oedema]. Bogachev VI; Boldin BV; Turkin PI; Samenkov AI Angiol Sosud Khir; 2020; 26(2):86-94. PubMed ID: 32597888 [TBL] [Abstract][Full Text] [Related]
14. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study. Zagriadskiĭ EA; Bogomazov AM; Golovko EB Adv Ther; 2018 Nov; 35(11):1979-1992. PubMed ID: 30276625 [TBL] [Abstract][Full Text] [Related]
15. [Comparative efficacy of various methods of treatment of chronic venous oedema in real clinical practice]. Bogachev VI; Boldin BV; Turkin PI; Samenkov AI; Angiol Sosud Khir; 2021; 27(3):77-83. PubMed ID: 34528591 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial. Carpentier P; van Bellen B; Karetova D; Hanafiah H; Enriquez-Vega E; Kirienko A; Dzupina A; Sabovic M; Reina Gutierrez L; Subwongcharoen S; Tüzün H; Maggioli A Int Angiol; 2017 Oct; 36(5):402-409. PubMed ID: 28206732 [TBL] [Abstract][Full Text] [Related]
17. Clinical acceptability study of once-daily versus twice-daily micronized purified flavonoid fraction in patients with symptomatic chronic venous disease: a randomized controlled trial. Kirienko A; Radak D Int Angiol; 2016 Aug; 35(4):399-405. PubMed ID: 26576663 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial. Rabe E; Agus GB; Roztocil K Int Angiol; 2015 Oct; 34(5):428-36. PubMed ID: 25972136 [TBL] [Abstract][Full Text] [Related]
20. Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins. Pietrzycka A; Kózka M; Urbanek T; Stpniewski M; Kucharzewski M Curr Vasc Pharmacol; 2015; 13(6):801-8. PubMed ID: 26311575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]